|  Help  |  About  |  Contact Us

Publication : Droplet-based forward genetic screening of astrocyte-microglia cross-talk.

First Author  Wheeler MA Year  2023
Journal  Science Volume  379
Issue  6636 Pages  1023-1030
PubMed ID  36893254 Mgi Jnum  J:341871
Mgi Id  MGI:7465238 Doi  10.1126/science.abq4822
Citation  Wheeler MA, et al. (2023) Droplet-based forward genetic screening of astrocyte-microglia cross-talk. Science 379(6636):1023-1030
abstractText  Cell-cell interactions in the central nervous system play important roles in neurologic diseases. However, little is known about the specific molecular pathways involved, and methods for their systematic identification are limited. Here, we developed a forward genetic screening platform that combines CRISPR-Cas9 perturbations, cell coculture in picoliter droplets, and microfluidic-based fluorescence-activated droplet sorting to identify mechanisms of cell-cell communication. We used SPEAC-seq (systematic perturbation of encapsulated associated cells followed by sequencing), in combination with in vivo genetic perturbations, to identify microglia-produced amphiregulin as a suppressor of disease-promoting astrocyte responses in multiple sclerosis preclinical models and clinical samples. Thus, SPEAC-seq enables the high-throughput systematic identification of cell-cell communication mechanisms.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

31 Bio Entities

Trail: Publication

0 Expression